Patent details

EP3672622 Title: RECOMBINANT HUMAN ACID SPHINGOMYELINASE FOR USE IN TREATING ABNORMAL BONE CONDITIONS IN ACID SPHINGOMYELINASE DEFICIENCY PATIENTS

Basic Information

Publication number:
EP3672622
PCT Application Number:
IB2018056346
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP187689484
PCT Publication Number:
WO2019038685
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
RECOMBINANT HUMAN ACID SPHINGOMYELINASE FOR USE IN TREATING ABNORMAL BONE CONDITIONS IN ACID SPHINGOMYELINASE DEFICIENCY PATIENTS
French Title of Invention:
SPHINGOMYELINASE ACIDE HUMAIN RECOMBINANTE POUR L'UTILISATION DANS LE TRAITEMENT D'ÉTATS OSSEUX ANORMAUX CHEZ DES PATIENTS PRÉSENTANT UNE DÉFICIENCE EN SPHINGOMYÉLINASE ACIDE
German Title of Invention:
REKOMBINANTE MENSCHLICHE ACID SPHINGOMYELINASE ZUR VERWENDUNG IN DER BEHANDLUNG VON ABNORMALEN KNOCHENERKRANKUNGEN BEI PATIENTEN MIT SAURE-SPHINGOMYELINASE-MANGEL
SPC Number:

Dates

Filing date:
22/08/2018
Grant date:
08/11/2023
EP Publication Date:
01/07/2020
PCT Publication Date:
28/02/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/11/2023
EP B1 Publication Date:
08/11/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/08/2024
Expiration date:
22/08/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/11/2023
 
 

Name:
Genzyme Corporation
Address:
450 Water Street, Cambridge, MA 02141, United States (US)

Inventor

Name:
SCHEIDT-PUGA, Ana Cristina
Address:
France (FR)

Priority

1

Priority Number:
201762549732 P
Priority Date:
24/08/2017
Priority Country:
United States (US)

2

Priority Number:
17306720
Priority Date:
07/12/2017
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 38/46; A61P 3/00; A61P 19/10; A61P 19/08;

Publication

European Patent Bulletin

Issue number:
202345
Publication date:
08/11/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages